Suven Life Sciences surges on bourses

Mumbai, November 12 (Udaipur Kiran): Suven Life Sciences is currently trading at Rs. 282.35, up by 4.35 points or 1.56% from its previous closing of Rs. 278.00 on the BSE.

The scrip opened at Rs. 277.80 and has touched a high and low of Rs. 285.00 and Rs. 276.80 respectively. So far 21239 shares were traded on the counter.

The BSE group ‘B’ stock of face value Rs. 1 has touched a 52 week high of Rs. 402.90 on 01-Sep-2026 and a 52 week low of Rs. 124.35 on 24-Mar-2026.

Last one week high and low of the scrip stood at Rs. 292.55 and Rs. 262.70 respectively. The current market cap of the company is Rs. 7961.20 crore.

The promoters holding in the company stood at 65.47%, while Institutions and Non-Institutions held 2.63% and 31.90% respectively.

Suven Life Sciences is all set to present seven scientific posters highlighting its drug discovery and development programs at Neuroscience 2026, the annual meeting of the Society for Neuroscience (SfN), to be held in Washington, DC, USA, during November 14-18, 2026. Society for Neuroscience (SfN), is the world’s largest organization of scientists and physicians devoted to understanding the brain and nervous system, famous for its massive annual global conference.

The presentations span a diverse range of therapeutic areas, including Alzheimer’s Disease, Agitation, Schizophrenia, Narcolepsy, Sleep Disorders, Major Depressive Disorder and Parkinson’s Disease. The posters highlight the company’s continued progress in advancing innovative drug candidates through clinical and preclinical development.

Suven Life Sciences provides wide range of Drug Discovery and Development Support Services (DDDSS) to global Pharma and Biotech companies. It has state-of-art facilities with highly qualified & experienced team of scientists.